Overview

Paroxetine in the Treatment of Chronic Primary Insomnia

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The goal of the study is to examine the role of paroxetine, an antidepressant medication, in the acute and continuation treatment of insomnia. Primary insomnia is a type of insomnia not directly resulting from general medical, chemical, or psychiatric conditions.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
GlaxoSmithKline
Treatments:
Paroxetine